Comparison of Early Outcomes of Stereotactic Accelerated Partial Breast Irradiation vs. Volumetric Modulated Arc Therapy-Based FAST-FORWARD Whole Breast Irradiation for Breast Cancer (2357)
J. Chang, J. Lee, F. A. Vicini, J. S. Kim, J. Kim, S. H. Choi, H. K. Byun, I. J. Lee, and Y. B. Kim | ASTRO | 2023
Early Results of a Phase I Pre-Operative Single Fraction Ablative Trial for Early Stage Breast Cancer (LBA 11)
A. S. Rahimi, M. Leitch, B. Dogan, P. G. Alluri, D. Farr, M. Arbab, S. Seiler, D. W. N. Kim, R. Wooldridge, N. Unni, C. R. Nwachukwu, I. Patel, Y. Zhang, D. D. M. Parsons, A. Nguyen, H. E. Morgan, H. L. McArthur, S. Sahoo, and R. D. Timmerman | ASTRO | 2023
Decreasing Skin Toxicity in Whole Breast Irradiation with Helical TomoTherapy IMRT (2350)
A. Alphonse, S. Whalen, S. Richter, and R. K. Benda | ASTRO | 2023
Plan Quality Comparison at 5 Years in 2 Cohorts of Breast Cancer Patients Treated with TomoTherapy
S. Dicuonzo, M. Zaffaroni, K.M.S.A. Amin, G. Ronci, M. D’Arcangelo, M.G. Vincini, R. Cambria, R. Luraschi, D.P.Rojas, M.A. Zerella, F. Cattani, R. Orecchia, M.C. Leonardi, B.A. Jereczek-Fossa | PO-2044 | ESTRO | 2023
Outcomes of Hypofractionated Locoregional Radiotherapy in Advanced Breast Cancer
R. Tummineri, A. Fodor, F. Zerbetto, M. Midulla, M. Pasetti, C.L. Deantoni, R. Castriconi, P. Mangili, A. Del Vecchio, N.G. Di Muzio | PO-1248 | ESTRO | 2023
Halfmoon Radiotherapy: A Real-world Experience in a Single Institution
Maria Alessia Zerella, Samantha Dicuonzo, Mattia Zaffaroni, Marianna Alessandra Gerardi, Damaris Patricia Rojas, Anna Morra, Denis Nicolò, Raffaella Cambria, Rosa Luraschi, Federica Cattani, Roberto Orecchia, Maria Cristina Leonardi, Barbara Alicja Jereczek-Fossa | PO-1278 | ESTRO | 2023
Partial Breast Re-irradiation with IMRT for Local Recurrence after Whole Breast Radiotherapy
Simona Arculeo, Samantha Dicuonzo, Anna Morra, Marianna Alessandra Gerardi, Lorenzo Colombi, Colombi Lorenzo, Federica Cattani, Stefania Comi, Paolo Veronesi, Viviana Galimberti, Mattia Zaffaroni, Maria Alessia Zerella, Roberto Orecchia, Maria Cristina Leonardi, Barbara Alicja Jereczek-Fossa | PO-1251 | ESTRO | 2023
Stereotactic APBI for Early-stage Breast Cancer: 3-year Outcomes of a Prospective Registry
Jonathan Cantalino, Monica Pernia Marin, David D’Ambrosio, Arica Hirsch, Malika Danner, Sonali Rudra, Simeng Suy, Sean Collins, Dawn Matsanka, Michael Good, Jing Feng, John Lamond, Deborah Markiewicz, Rachelle Lanciano, Olusola Obayomi-Davies, Brian Collins | PO-1249 | ESTRO | 2023
2026: Efficacy of SBRT in High Volume Metastatic Carcinoma Breast – A Berry Picking Approach in the Era of High Precision Radiotherapy
P.S. Sridhar, P. Anuradha, C. Fareena Taj, S. Suresh, K. Roopesh, R. Ghosh, S. Bj, | ASTRO | 2022
2031: Evaluation of Early Cosmetic Outcome and Toxicity after 5-Fraction Stereotactic Partial Breast Irradiation in Early-Stage Breast Cancer: A Prospective Cohort Study
H.K. Byun, J.S. Chang, H.J. Kim, J. Kim, M.C. Han, S.Y. KIM, R.H. PARK, C.J. Kim, and Y.B. Kim | ASTRO | 2022
Estimation of Annual Secondary Lung Cancer Deaths Using Various Adjuvant Breast Radiotherapy Techniques for Early-Stage Cancers
Jean-Philippe Pignol, Nienke Hoekstra, Derek Wilke, Hannah Dahn, Maureen Nolan, Frank Vicini | Front Oncol | 2021
Skin Toxicity in Early Breast Cancer Patients Treated with Field-In-Field Breast Intensity-Modulated Radiotherapy versus Helical Inverse Breast Intensity-Modulated Radiotherapy: Results of a Phase III Randomised Controlled Trial
K Joseph, L J Vos, Z Gabos, N Pervez, S Chafe, K Tankel, H Warkentin, S Ghosh, J Amanie, K Powell, L-A Polkosnik, S Horsman, M MacKenzie, S Sabri, M B Parliament, J Mackey, B Abdulkarim | Clin Oncol (R Coll Radiol) | 2021
Using the Tomotherapy® System for Whole Breast Irradiation in the Community Clinic Setting
Robert A. Harris
Benefits of TomoDirect™ to Treat Breast Cancer
Nathan Corradini
Breast Cancer: Your Challenges Today – Our Solutions for Tomorrow
Nathan Corradini, Jennifer R. Bellon
A Comprehensive Radiotherapy Strategy for Managing Breast Cancer
Rupesh Kotecha
Clinical Outcomes and Dosimetric Study of Hypofractionated Helical TomoTherapy® in Breast Cancer Patients
Imjai Chitapanarux
Hypofractionated postmastectomy radiotherapy with helical tomotherapy in patients with immediate breast reconstruction: dosimetric results and acute/intermediate toxicity evaluation
Orecchia R, Rojas DP, Cattani F, Ricotti R, Santoro L, Morra A, Cambria R, Luraschi R, Dicuonzo S, Ronchi S, Surgo A, Dell’ Acqua V, Veronesi P, De Lorenzi F, Fodor C, Leonardi MC, Jereczek-Fossa BA | Med Oncol | 2018
Use of helical tomotherapy in locally advanced and/or metastatic breast cancer for locoregional treatment
Thery L, Arsene-Henry A, Carroll S, Peurien D, Bazire L, Robilliard M, Fourquet A, Kirova YM | Br J Radiol | 2018
The use of helical tomotherapy in the treatment of early stage breast cancer: indications, tolerance, efficacy-a single center experience
Arsene-Henry A, Foy JP, Robilliard M, Xu HP, Bazire L, Peurien D, Poortmans P, Fourquet A, Kirova YM | Oncotarget | 2018
